NS Utay

Pharmacokinetics, Safety, and CCR2/CCR5 Antagonist Activity of Cenicriviroc in Participants With Mild or Moderate Hepatic Impairment

A. Somasunderam, K. Lasseter, M. Gottwald, 2016, Clinical and translational science.